Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-24 @ 7:22 PM
NCT ID:
NCT00805103
Eligibility Criteria:
Inclusion Criteria:
* 1-5 recurrent brain metastases after WBRT, and
* At least 1 lesions \>2cm in maximum diameter
* ECOG 0-2
* Life expectancy \>3months
* Age ≥ 18 years old
Exclusion Criteria:
* Edentulous patients
* Prior surgery or injury to hard palate
* Severe claustrophobia
* Contraindication to MRI
* Contraindication to IV contrast (Gadolinium) administration
* Other medical conditions that would preclude study investigations
* Prior radiosurgery to recurrent lesions
* Radiation cannot be delivered at the assigned dose level in a manner that respects OAR constraints (3.2.2.4.2.3.4) (e.g. lesions within brainstem or abutting optic structures)
* Any lesion \>5cm in diameter, or total volume of tumor \> 60cc
* Pregnant Women
* Men or women of childbearing potential who are unwilling to employ adequate contraception
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00805103
Study Brief:
Protocol Section:
NCT00805103